Evidence that the endosomal sorting complex required for transport-II (ESCRT-II) is required for efficient human immunodeficiency virus-1 (HIV-1) production
暂无分享,去创建一个
[1] D. Nachmias,et al. Inhibition of ESCRT-II–CHMP6 interactions impedes cytokinetic abscission and leads to cell death , 2014, Molecular biology of the cell.
[2] Prabuddha Sengupta,et al. Distribution of ESCRT Machinery at HIV Assembly Sites Reveals Virus Scaffolding of ESCRT Subunits , 2014, Science.
[3] Bo Meng,et al. Wrapping up the bad news – HIV assembly and release , 2013, Retrovirology.
[4] J. Hurley,et al. In vitro reconstitution of the ordered assembly of the endosomal sorting complex required for transport at membrane-bound HIV-1 Gag clusters , 2012, Proceedings of the National Academy of Sciences.
[5] Anne L’hernault,et al. HIV-2 Genome Dimerization Is Required for the Correct Processing of Gag: a Second-Site Reversion in Matrix Can Restore Both Processes in Dimerization-Impaired Mutant Viruses , 2012, Journal of Virology.
[6] W. Sundquist,et al. ESCRT-III protein requirements for HIV-1 budding. , 2011, Cell host & microbe.
[7] P. Bieniasz,et al. Dynamics of ESCRT protein recruitment during retroviral assembly , 2011, Nature Cell Biology.
[8] K. Nagashima,et al. Basic Residues in the Nucleocapsid Domain of Gag Are Critical for Late Events of HIV-1 Budding , 2010, Journal of Virology.
[9] J. Hurley,et al. Membrane budding and scission by the ESCRT machinery: it's all in the neck , 2010, Nature Reviews Molecular Cell Biology.
[10] S. Emr,et al. ESCRT‐II coordinates the assembly of ESCRT‐III filaments for cargo sorting and multivesicular body vesicle formation , 2010, The EMBO journal.
[11] J. Hurley,et al. Molecular Mechanism of Multivesicular Body Biogenesis by ESCRT Complexes , 2010, Nature.
[12] Karl Rohr,et al. Dynamics of HIV-1 Assembly and Release , 2009, PLoS pathogens.
[13] K. Nagashima,et al. Functional role of Alix in HIV-1 replication. , 2009, Virology.
[14] J. Hurley,et al. Structure and function of the ESCRT-II-III interface in multivesicular body biogenesis. , 2009, Developmental cell.
[15] Kunio Nagashima,et al. The Nucleocapsid Region of HIV-1 Gag Cooperates with the PTAP and LYPXnL Late Domains to Recruit the Cellular Machinery Necessary for Viral Budding , 2009, PLoS pathogens.
[16] Marc C. Johnson,et al. Three-dimensional analysis of budding sites and released virus suggests a revised model for HIV-1 morphogenesis. , 2008, Cell host & microbe.
[17] G. Medina,et al. Avian Sarcoma Virus and Human Immunodeficiency Virus, Type 1 Use Different Subsets of ESCRT Proteins to Facilitate the Budding Process* , 2008, Journal of Biological Chemistry.
[18] Sanford M. Simon,et al. Imaging the biogenesis of individual HIV-1 virions in live cells , 2008, Nature.
[19] J. Hurley,et al. Integrated structural model and membrane targeting mechanism of the human ESCRT-II complex. , 2008, Developmental cell.
[20] R. D. Fisher,et al. ALIX-CHMP4 interactions in the human ESCRT pathway , 2008, Proceedings of the National Academy of Sciences.
[21] B. Berkhout,et al. RNA Structure Modulates Splicing Efficiency at the Human Immunodeficiency Virus Type 1 Major Splice Donor , 2007, Journal of Virology.
[22] J. Hurley,et al. Beyond Tsg101: the role of Alix in 'ESCRTing' HIV-1 , 2007, Nature Reviews Microbiology.
[23] A. Brech,et al. Vps22/EAP30 in ESCRT‐II Mediates Endosomal Sorting of Growth Factor and Chemokine Receptors Destined for Lysosomal Degradation , 2007, Traffic.
[24] W. Sundquist,et al. The molecular mechanism of hepcidin-mediated ferroportin down-regulation. , 2007, Molecular biology of the cell.
[25] J. Martin-Serrano,et al. Parallels Between Cytokinesis and Retroviral Budding: A Role for the ESCRT Machinery , 2007, Science.
[26] R. D. Fisher,et al. Structural and Biochemical Studies of ALIX/AIP1 and Its Role in Retrovirus Budding , 2007, Cell.
[27] S. Emr,et al. Structural insight into the ESCRT‐I/‐II link and its role in MVB trafficking , 2007, The EMBO journal.
[28] R. D. Fisher,et al. Human ESCRT-II Complex and Its Role in Human Immunodeficiency Virus Type 1 Release , 2006, Journal of Virology.
[29] S. Emr,et al. ESCRT-I Core and ESCRT-II GLUE Domain Structures Reveal Role for GLUE in Linking to ESCRT-I and Membranes , 2006, Cell.
[30] P. Lehner,et al. Degradation of Endocytosed Epidermal Growth Factor and Virally Ubiquitinated Major Histocompatibility Complex Class I Is Independent of Mammalian ESCRTII* , 2006, Journal of Biological Chemistry.
[31] H. Stenmark,et al. Eap45 in Mammalian ESCRT-II Binds Ubiquitin via a Phosphoinositide-interacting GLUE Domain*♦ , 2005, Journal of Biological Chemistry.
[32] K. Jeang,et al. Requirement of DDX3 DEAD Box RNA Helicase for HIV-1 Rev-RRE Export Function , 2004, Cell.
[33] B. González,et al. ESCRT-II, an endosome-associated complex required for protein sorting: crystal structure and interactions with ESCRT-III and membranes. , 2004, Developmental cell.
[34] Scott D. Emr,et al. Structure of the ESCRT-II endosomal trafficking complex , 2004, Nature.
[35] P. Bieniasz,et al. A Bipartite Late-Budding Domain in Human Immunodeficiency Virus Type 1 , 2003, Journal of Virology.
[36] A. Calistri,et al. AIP1/ALIX Is a Binding Partner for HIV-1 p6 and EIAV p9 Functioning in Virus Budding , 2003, Cell.
[37] F. Holstege,et al. Specific inhibition of gene expression using a stably integrated, inducible small‐interfering‐RNA vector , 2003, EMBO reports.
[38] Wesley I. Sundquist,et al. Functional Surfaces of the Human Immunodeficiency Virus Type 1 Capsid Protein , 2003, Journal of Virology.
[39] E. Freed. The HIV-TSG101 interface: recent advances in a budding field. , 2003, Trends in microbiology.
[40] W. B. Snyder,et al. Endosome-associated complex, ESCRT-II, recruits transport machinery for protein sorting at the multivesicular body. , 2002, Developmental cell.
[41] J. Kappes,et al. Emergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor (T-20) Monotherapy , 2002, Antimicrobial Agents and Chemotherapy.
[42] E. Freed,et al. Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[43] E. Freed,et al. The Late Domain of Human Immunodeficiency Virus Type 1 p6 Promotes Virus Release in a Cell Type-Dependent Manner , 2002, Journal of Virology.
[44] D. Kim,et al. Improved expression of vascular endothelial growth factor by naked DNA in mouse skeletal muscles: implication for gene therapy of ischemic diseases. , 2000, Biochemical and biophysical research communications.
[45] S. Emr,et al. Mammalian Tumor Susceptibility Gene 101 (TSG101) and the Yeast Homologue, Vps23p, Both Function in Late Endosomal Trafficking , 2000, Traffic.
[46] A. Shilatifard,et al. Cloning and Characterization of the EAP30 Subunit of the ELL Complex That Confers Derepression of Transcription by RNA Polymerase II* , 1999, The Journal of Biological Chemistry.
[47] B. Chesebro,et al. Effects of CCR5 and CD4 Cell Surface Concentrations on Infections by Macrophagetropic Isolates of Human Immunodeficiency Virus Type 1 , 1998, Journal of Virology.
[48] A. Lever,et al. Helper virus-free transfer of human immunodeficiency virus type 1 vectors. , 1995, The Journal of general virology.
[49] M. Emerman,et al. Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI. , 1991, Virology.
[50] J. Sodroski,et al. Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[51] J. Kusari,et al. Functional equivalents of interferon‐mediated signals needed for induction of an mRNA can be generated by double‐stranded RNA and growth factors. , 1987, The EMBO journal.
[52] Amanda G. Fisher,et al. A molecular clone of HTLV-III with biological activity , 1985, Nature.